These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 23268200

  • 1. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S.
    Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
    [Abstract] [Full Text] [Related]

  • 2. Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy.
    Wen HL, Lin YT, Ting CH, Lin-Chao S, Li H, Hsieh-Li HM.
    Hum Mol Genet; 2010 May 01; 19(9):1766-78. PubMed ID: 20176735
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H, Beauvais A, Baker AN, Tsilfidis C, Kothary R.
    Dev Neurobiol; 2011 Feb 01; 71(2):153-69. PubMed ID: 20862739
    [Abstract] [Full Text] [Related]

  • 5. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K, Yadav P, Giegerich M, Cheong PS, Graf M, Vyas H, Lee SG, Mathavan S, Fischer U, Sendtner M, Winkler C.
    Hum Mol Genet; 2014 Apr 01; 23(7):1754-70. PubMed ID: 24218366
    [Abstract] [Full Text] [Related]

  • 6. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M, Ackermann B, Förster A, Jakubik M, Hauke J, Garbes L, Fritzsche I, Mende Y, Blumcke I, Hahnen E, Wirth B.
    Hum Mol Genet; 2010 Apr 15; 19(8):1492-506. PubMed ID: 20097677
    [Abstract] [Full Text] [Related]

  • 7. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H, Shafey D, Moores JN, Kothary R.
    J Neurosci Res; 2010 Jan 15; 88(1):111-22. PubMed ID: 19642194
    [Abstract] [Full Text] [Related]

  • 8. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, Thabet M, Paul B, Reilly A, Gagnon S, Renaud JM, Kothary R.
    EBioMedicine; 2020 May 15; 55():102750. PubMed ID: 32339936
    [Abstract] [Full Text] [Related]

  • 9. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
    Garcera A, Mincheva S, Gou-Fabregas M, Caraballo-Miralles V, Lladó J, Comella JX, Soler RM.
    Neurobiol Dis; 2011 Jun 15; 42(3):415-26. PubMed ID: 21333739
    [Abstract] [Full Text] [Related]

  • 10. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
    Rindt H, Buckley DM, Vale SM, Krogman M, Rose FF, Garcia ML, Lorson CL.
    Neuromuscul Disord; 2012 Mar 15; 22(3):277-85. PubMed ID: 22079083
    [Abstract] [Full Text] [Related]

  • 11. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Bhanot K, Kothary R.
    Neurobiol Dis; 2013 Jan 15; 49():57-67. PubMed ID: 22960106
    [Abstract] [Full Text] [Related]

  • 12. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, Carcenac R, Astord S, Pereira de Moura A, Voit T, Barkats M.
    Hum Mol Genet; 2011 Feb 15; 20(4):681-93. PubMed ID: 21118896
    [Abstract] [Full Text] [Related]

  • 13. Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy.
    Wang LT, Chiou SS, Liao YM, Jong YJ, Hsu SH.
    Kaohsiung J Med Sci; 2014 May 15; 30(5):229-34. PubMed ID: 24751385
    [Abstract] [Full Text] [Related]

  • 14. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE, Nguyen TT, Grunseich C, Nofziger JH, Lee PR, Fields D, Fischbeck KH, Foran E.
    J Neurosci; 2017 May 24; 37(21):5309-5318. PubMed ID: 28450545
    [Abstract] [Full Text] [Related]

  • 15. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL.
    Hum Mol Genet; 2010 Oct 15; 19(20):4059-71. PubMed ID: 20696672
    [Abstract] [Full Text] [Related]

  • 16. Spinal muscular atrophy: going beyond the motor neuron.
    Hamilton G, Gillingwater TH.
    Trends Mol Med; 2013 Jan 15; 19(1):40-50. PubMed ID: 23228902
    [Abstract] [Full Text] [Related]

  • 17. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y, Ono Y, Nagahara Y, Noda Y, Kameyama T, Ando S, Tsuruma K, Shimazawa M, Hara H, Kaneko H.
    Stem Cells Transl Med; 2016 Feb 15; 5(2):152-63. PubMed ID: 26683872
    [Abstract] [Full Text] [Related]

  • 18. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 19. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R.
    Neuromuscul Disord; 2012 Mar 15; 22(3):263-76. PubMed ID: 22071333
    [Abstract] [Full Text] [Related]

  • 20. SMN in spinal muscular atrophy and snRNP biogenesis.
    Coady TH, Lorson CL.
    Wiley Interdiscip Rev RNA; 2011 Mar 15; 2(4):546-64. PubMed ID: 21957043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.